Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

Implications of new hypertension guidelines in the United States.

Bertoia ML, Waring ME, Gupta PS, Roberts MB, Eaton CB.

Hypertension. 2011 Sep;58(3):361-6. doi: 10.1161/HYPERTENSIONAHA.111.175463. Epub 2011 Jul 18. Retraction in: Hypertension. 2012 Sep;60(3):e29.

2.

Implications of new hypertension guidelines in the United States.

Bertoia ML, Waring ME, Gupta PS, Roberts MB, Eaton CB.

Hypertension. 2012 Sep;60(3):639-44. doi: 10.1161/HYPERTENSIONAHA.112.193714. Epub 2012 Aug 6.

3.

Can Antihypertensive Treatment Restore the Risk of Cardiovascular Disease to Ideal Levels?: The Coronary Artery Risk Development in Young Adults (CARDIA) Study and the Multi-Ethnic Study of Atherosclerosis (MESA).

Liu K, Colangelo LA, Daviglus ML, Goff DC, Pletcher M, Schreiner PJ, Sibley CT, Burke GL, Post WS, Michos ED, Lloyd-Jones DM.

J Am Heart Assoc. 2015 Sep 21;4(9):e002275. doi: 10.1161/JAHA.115.002275.

4.

Vital signs: prevalence, treatment, and control of hypertension--United States, 1999-2002 and 2005-2008.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2011 Feb 4;60(4):103-8.

5.

Vital signs: awareness and treatment of uncontrolled hypertension among adults--United States, 2003-2010.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2012 Sep 7;61:703-9.

7.

Hypertension and coronary artery disease: a summary of the American Heart Association scientific statement.

Rosendorff C.

J Clin Hypertens (Greenwich). 2007 Oct;9(10):790-5. Review. Erratum in: J Clin Hypertens (Greenwich). 2007 Dec;9(12):976.

8.
9.
10.

Ethnic/racial variations in blood pressure awareness, treatment, and control.

Giles T, Aranda JM Jr, Suh DC, Choi IS, Preblick R, Rocha R, Frech-Tamas F.

J Clin Hypertens (Greenwich). 2007 May;9(5):345-54.

11.

Hypertension control and antihypertensive therapy in patients with chronic kidney disease.

Unni S, White K, Goodman M, Ye X, Mavros P, Bash LD, Brixner D.

Am J Hypertens. 2015 Jun;28(6):814-22. doi: 10.1093/ajh/hpu215. Epub 2014 Nov 24.

PMID:
25421796
12.
13.

Generalizability of SPRINT Results to the U.S. Adult Population.

Bress AP, Tanner RM, Hess R, Colantonio LD, Shimbo D, Muntner P.

J Am Coll Cardiol. 2016 Feb 9;67(5):463-72. doi: 10.1016/j.jacc.2015.10.037. Epub 2015 Nov 9.

14.
15.

Prevalence of resistant hypertension in the United States, 2003-2008.

Persell SD.

Hypertension. 2011 Jun;57(6):1076-80. doi: 10.1161/HYPERTENSIONAHA.111.170308. Epub 2011 Apr 18.

16.

US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008.

Egan BM, Zhao Y, Axon RN.

JAMA. 2010 May 26;303(20):2043-50. doi: 10.1001/jama.2010.650.

PMID:
20501926
17.

Inadequate control of hypertension in US adults with cardiovascular disease comorbidities in 2003-2004.

Wong ND, Lopez VA, L'Italien G, Chen R, Kline SE, Franklin SS.

Arch Intern Med. 2007 Dec 10;167(22):2431-6.

PMID:
18071164
18.

Blood pressure control and drug therapy in patients with diagnosed hypertension: a survey in Italian general practice.

Filippi A, Paolini I, Innocenti F, Mazzaglia G, Battaggia A, Brignoli O.

J Hum Hypertens. 2009 Nov;23(11):758-63. doi: 10.1038/jhh.2009.14. Epub 2009 Feb 26.

PMID:
19242492
19.

Blood pressure targets and absolute cardiovascular risk.

Odutayo A, Rahimi K, Hsiao AJ, Emdin CA.

Hypertension. 2015 Aug;66(2):280-5. doi: 10.1161/HYPERTENSIONAHA.114.04997. Epub 2015 Jun 8.

20.

Blood pressure control among persons without and with chronic kidney disease: US trends and risk factors 1999-2006.

Plantinga LC, Miller ER 3rd, Stevens LA, Saran R, Messer K, Flowers N, Geiss L, Powe NR; Centers for Disease Control and Prevention Chronic Kidney Disease Surveillance Team.

Hypertension. 2009 Jul;54(1):47-56. doi: 10.1161/HYPERTENSIONAHA.109.129841. Epub 2009 May 26.

Supplemental Content

Support Center